Elusive goal of targeting tumor hypoxia for therapeutic gain
- PMID: 22508811
- DOI: 10.1200/JCO.2011.40.8294
Elusive goal of targeting tumor hypoxia for therapeutic gain
Comment on
-
Accelerated radiotherapy with carbogen and nicotinamide for laryngeal cancer: results of a phase III randomized trial.J Clin Oncol. 2012 May 20;30(15):1777-83. doi: 10.1200/JCO.2011.35.9315. Epub 2012 Apr 16. J Clin Oncol. 2012. PMID: 22508814 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
